Hill August 29, 2023
The Biden administration has announced the first 10 drugs chosen for Medicare price negotiation, representing a major step in Democratic efforts to address health care affordability in the U.S.
However, the entire program is being contested in the courts by major pharmaceutical companies and industry groups, which could potentially delay or even halt implementation, with savings currently set to take effect in 2026.
While the discounted prices anticipated to result from the Medicare Drug Price Negotiation Program will only apply to those enrolled in Medicare, advocates are hoping this federal action will have a ripple effect spreading across the pharmaceutical industry.
The Centers for Medicare and Medicaid (CMS) looked at Medicare Part D drug use between June 1, 2022,...
Today's Sponsors
Today's Sponsor